Schonfeld Strategic Advisors LLC Chroma Dex Corp. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 12,700 shares of CDXC stock, worth $74,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,700Holding current value
$74,549% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
129Shares Held
21.9MCall Options Held
203KPut Options Held
23.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$19.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$18.3 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.59MShares$15.2 Million5.52% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.61 Million0.14% of portfolio
-
Geode Capital Management, LLC Boston, MA1.15MShares$6.78 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $401M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...